Skip to main content
logo
Azenta, Inc. (LON:0HQ1)
London flag London · Delayed Price · Currency is GBP · Price in USD
38.83
+0.85 (2.24%)
Jan 14, 2026, 4:15 PM GMT

Revenue by Geography

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222017 - 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2017 - 2021
United States Revenue
365.00M
Log In
Log In
Log In
Upgrade
Africa Revenue
-
Log In
Log In
Log In
Upgrade
China Revenue
58.35M
Log In
Log In
Log In
Upgrade
United Kingdom Revenue
35.39M
Log In
Log In
Log In
Upgrade
Rest of Europe Revenue
107.37M
Log In
Log In
Log In
Upgrade
Asia Pacific/ Other Revenue
27.71M
Log In
Log In
Log In
Upgrade
Revenue (Total)
593.82M
Log In
Log In
Log In
Upgrade

Revenue Breakdown

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222017 - 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2017 - 2021
Sample Management Solutions Revenue
324.59M
Log In
Log In
Log In
Upgrade
Multiomics Revenue
269.23M
Log In
Log In
Log In
Upgrade
Revenue (Total)
593.82M
Log In
Log In
Log In
Upgrade

Revenue Breakdown 3

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222017 - 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2017 - 2021
Multiomics Revenue
269.23M
Log In
Log In
Log In
Upgrade
Core Products Revenue
197.63M
Log In
Log In
Log In
Upgrade
Sample Repository Solutions Revenue
126.96M
Log In
Log In
Log In
Upgrade
Revenue (Total)
593.82M
Log In
Log In
Log In
Upgrade

Adjusted EBIT

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222017 - 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2017 - 2021
Sample Management Solutions Adjusted Operating Income
27.55M
Log In
Log In
Log In
Upgrade
Multiomics Adjusted Operating Income
-11.94M
Log In
Log In
Log In
Upgrade
Operating Income (Total)
-26.84M
Log In
Log In
Log In
Upgrade

Adjusted EBIT 2

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222017 - 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2017 - 2021
Life Sciences Product Adjusted Operating Income
-
Log In
Log In
Log In
Upgrade
Life Sciences Services Adjusted Operating Income
-
Log In
Log In
Log In
Upgrade
Operating Income (Total)
-26.84M
Log In
Log In
Log In
Upgrade

Key Performance Indicators

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222017 - 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2017 - 2021
Organic Revenue Growth
3.00%
Log In
Log In
Log In
Upgrade
Updated Sep 30, 2025. Data Source: Fiscal.ai.